Harrow Inc (HROW)
26.79 x 1 28.80 x 1
Post-market by (Cboe BZX)
28.41 +0.32 (+1.14%) 03/21/25 [NASDAQ]
26.79 x 1 28.80 x 1
Post-market 28.22 -0.19 (-0.67%) 18:15 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | HROW | ELVN | COLL | ||
| Company | Harrow Inc | Enliven Therapeutics Inc | Collegium Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.75 | 20.64 | 29.74 | ||
| High | 28.70 | 21.41 | 30.53 | ||
| Low | 27.59 | 20.55 | 29.25 | ||
| Last | 28.41 | 21.08 | 30.05 | ||
| Change | +0.32 | +0.16 | +0.12 | ||
| % Change | +1.14% | +0.76% | +0.40% | ||
| Volume | 625,600 | 412,500 | 2,287,700 | ||
| 20-Day Average Volume | 567,280 | 219,580 | 509,640 | ||
| Previous Close | 28.09 | 20.92 | 29.93 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 25.66 | 20.66 | 29.23 | ||
| 20-Day Raw Stochastic | 68.59% | 65.31% | 66.63% | ||
| 20-Day Relative Strength | 50.45% | 48.93% | 50.40% | ||
| Weighted Alpha | +32.08 | -5.39 | -22.64 | ||
| Today's Opinion | 64% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.47% since 03/14/25 | +1.64% since 03/14/25 | +2.00% since 03/14/25 | ||
| Low | 22.84 on 03/17/25 | 19.98 on 03/17/25 | 28.58 on 03/17/25 | ||
| High | 31.74 on 03/18/25 | 21.41 on 03/21/25 | 30.53 on 03/21/25 | ||
| 1-Month | |||||
| %Chg | -1.87% since 02/21/25 | -3.30% since 02/21/25 | +3.16% since 02/21/25 | ||
| Low | 21.14 on 03/10/25 | 18.67 on 03/04/25 | 27.27 on 03/05/25 | ||
| High | 31.74 on 03/18/25 | 22.36 on 03/06/25 | 31.44 on 02/28/25 | ||
| 3-Month | |||||
| %Chg | -16.98% since 12/20/24 | -6.19% since 12/20/24 | +1.18% since 12/20/24 | ||
| Low | 21.14 on 03/10/25 | 18.67 on 03/04/25 | 27.27 on 03/05/25 | ||
| High | 37.47 on 01/03/25 | 25.37 on 01/03/25 | 34.06 on 01/10/25 | ||
| 6-Month | |||||
| %Chg | -36.89% since 09/20/24 | -9.10% since 09/20/24 | -23.09% since 09/20/24 | ||
| Low | 21.14 on 03/10/25 | 18.67 on 03/04/25 | 27.27 on 03/05/25 | ||
| High | 59.23 on 10/18/24 | 30.03 on 10/18/24 | 42.29 on 10/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,011,822 | 1,033,004 | 946,154 | ||
| Shares Outstanding, K | 35,615 | 49,004 | 31,486 | ||
| Annual Sales | 130,190,000 | 0 | 631,450,000 | ||
| Annual Net Income | -24,410,000 | -89,020,000 | 69,190,000 | ||
| Last Quarter Sales | 49,260,000 | 0 | 181,950,000 | ||
| Last Quarter Net Income | -4,220,000 | -23,180,000 | 12,540,000 | ||
| 60-Month Beta | 0.69 | 1.04 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/13/24 | -0.46 on 03/13/25 | 1.77 on 02/27/25 | ||
| Latest Earnings Date | 03/17/25 | 05/13/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.11 | ||